News
LOS ANGELES -- Survival outcomes favored mechanical valves for isolated surgical aortic valve replacement (SAVR) for people until age 60, after which a tissue valve may start to have an advantage ...
"The latest COMMENCE aortic trial data emphasizes the value of RESILIA tissue-based offerings in helping patients and their physicians with lifetime management of valve disease." ...
Hosted on MSN10mon
New replacement heart valve combines mechanical and tissue ... - MSNWhen a patient needs a new heart valve, the current mechanical and tissue replacements each have strengths and weaknesses. Now, a team of UBC Okanagan researchers believe they have found a way to ...
A study presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that mechanical aortic valve replacements (AVRs) provide significant long-term survival benefits for ...
The following report presents 3 cases of intravascular hemolysis that followed aortic-valve replacement with cusps composed of Dacron cloth impregnated with silicone rubber. 8,9 Hematologic data ...
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace your aortic valve. The aortic valve controls blood flow from your heart to your aorta, the main artery that ...
LOS ANGELES, CA—In patients ages 60 years or younger undergoing surgical aortic valve replacement, mechanical valves are associated with a survival benefit compared with bioprosthetic valves, ...
Middle-aged adults who need an aortic valve replacement fare better with mechanical devices than with the valves made from animal tissues that they currently most often receive, U.S. researchers ...
New study finds mechanical valves offer superior long-term survival for aortic valve replacement patients aged 60 and younger Meeting Announcement The Society of Thoracic Surgeons image: ...
Dubbed the Epic Max, the stented, tissue-based valve is recommended for patients who need a replacement but shouldn’t take a regimen of blood thinners.
--Edwards Lifesciences today announced new data from the COMMENCE aortic trial, demonstrating low rates of structural valve deterioration in bioprosthetic aortic valves with the company's ...
The trial is evaluating the safety and effectiveness of Edwards' bioprosthetic aortic valve with RESILIA tissue in patients ages 18 and older with diagnosed aortic valve disease and scheduled to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results